CClinicalTrials.gg
CompletedNCT03272035REGIDAQUpdated Jan 23, 2019

General Practitioners' Felt With Their Patients' Death (REGIDAQ)

An observational study in Death, sponsored by University Hospital, Limoges. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2019-01-23.

Sponsored by University Hospital, Limoges · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
481
Sex
All
01

Study summary

Very few studies are dealing with the way general practitioners feel the death of their patients. Main studies about that subject are qualitative. It needs quantitative studies to analyse how is felt general practitioners' patients' death. This is an epidemiologic quantitative cross-sectional study. The Studied population is the whole of the general practitioners of the region Nouvelle-Aquitaine. The primary endpoint is the percentage of the general practitioners which have hard time living with their patients' death. The secondary endpoints are to evaluate the general practitioners' help needing after their patients' death, to evaluate the personal and professional impact of the patient's death, the percentage of general practitioners using chemical aid after their patients' death and to determinate the existence of support facilities to help general practitioners to stand patients' death. The results of that study could help general practitioners to improve their medical practice in the patient's death situation.

02

Conditions studied

  • Death

Browse trials for

Keywords

  • General practice
  • death
  • bereavement
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

General practitioners from the Nouvelle Aquitaine region

Inclusion criteria

  • General practitioners from the Nouvelle-Aquitaine region.
  • Exclusive or joint exercise of general medicine.
  • None retired

Exclusion criteria

Exclusion Criteria:

  • Retired patricians
  • Students, Residents
  • General practitioners from another region
  • General practitioners with no general medicine activity
04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
481 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. percentage of hard time living

    percentage of general practitioners which have hard time living with their patients' death

    Time frame: 2 months (End of study)

Secondary outcomes

  1. percentage of help needing

    percentage of general practitioners which need help after their patients' death

    Time frame: 2 months (End of study)

  2. percentage of personal impact

    percentage of general practitioners which have a personal impact when their patient's death

    Time frame: 2 months (End of study)

  3. percentage of professional impact

    percentage of general practitioners witch have a professional impact when the patient's death

    Time frame: 2 months (End of study)

  4. percentage of chemical aid using

    percentage of general practitioners using chemical aid after their patients' death

    Time frame: 2 months (End of study)

  5. support facilities

    Determinate the existence of support facilities to help general practitioners to stand patients' death

    Time frame: 2 months (End of study)

06

Study locations

1 site
  • University Hospital
    Limoges, 87042, France
07

Registry details

Key details

Study ID
NCT03272035
Lead sponsor
University Hospital, Limoges
Responsible party
Sponsor
First posted
Sep 5, 2017
Start date
Feb 13, 2018
Primary completion
May 13, 2018
Completion
May 13, 2018
Last update
Jan 23, 2019

Study contacts

Karen Rudelle, doctor
principal investigator · University Hospital, Limoges

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion